The Extinguish Trial: A Multi-Site Phase-2B Randomized Placebo-Controlled Trial to Study the Safety and Efficacy of Inebilizumab in Anti-NMDA Receptor EncephalitisGregory S. Day,Maarten J. Titulaer,Ka-Ho Wong,James Torner,Merit Cudkowicz,Christopher Coffey, Codrin Lungo, Eric Klawiter, J. Robert Singleton,Dana Mitchell,Janel Felder,Dixie Ecklund,David Klements,Michele Costigan,Stacey L. ClardyANNALS OF NEUROLOGY（2022）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
